CDXS — Codexis Inc · rev $30.2M

Codexis Inc (CDXS) is a biotechnology company listed on US.

Latest reported CDXS revenue for 2026-06-30 was $30.2M. Net income was -$20.7M. Revenue was up 97.8% from 2026-03-31 to 2026-06-30. CDXS currently screens at market cap $257.6M.

Use this CDXS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CDXS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CDXS SEC filings page. Lician reads the product cache first so this HTML stays unique to Codexis Inc even when a live quote feed is slow.

Codexis Inc latest statements (FY2025)

Latest cached year on this hub. Full CDXS income, balance, and cash tables.

  • Revenue$70.4M
  • Net Income-$44.0M
  • Total Assets$147.8M
  • Total Debt$0
  • Free Cash Flow-$23.8M

CDXS recent filings